GGrantIndex
← Leaderboards

Mark H Tuszynski

University Of California, San Diego

$42,403,260
Attributed
$54,667,943
Total exposure
51
Grants
39
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.9M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$62,431,286 · 45
VA$0 · 7

By mechanism

R01$36,994,156 · 10
P01$15,785,143 · 16
U01$4,598,301 · 1
K12$2,159,969 · 1
P51$1,168,270 · 12
R21$1,019,211 · 2

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposPrimatesSpinal Cord InjuryNeuronsRodentMacaca MulattaGene TherapyCellsSpinal CordMonkeysNatural RegenerationAxonRecovery Of FunctionLesionNonhuman PrimateBrainProgramsSiteTranslationsInjuryLeadRattusSynapsesClinical Trials

Grant awards (154)

Embryonic Stem Cell Therapy after Cervical Contusion SCI in NHPs$657,597
R01 · FY2025 · NS
The Primate Corticospinal Connectome and Transcriptome$627,913
R01 · FY2025 · NS · contact PI
RR&D Gordon Mansfield Spinal Cord Injury Consortium$0
I50 · FY2025 · VA · contact PI
RR&D Gordon Mansfield Spinal Cord Injury Consortium$0
I50 · FY2025 · VA · contact PI
SCI Consortium Study: 3D Printed Scaffolds for Primate Spinal Cord Injury Repair$0
I01 · FY2025 · VA
“Neural Stem Cells for Spinal Cord Injury: Studies leading to an IND”$0
IU1 · FY2025 · VA · contact PI
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease$795,037
R01 · FY2024 · AG · contact PI
Embryonic Stem Cell Therapy after Cervical Contusion SCI in NHPs$638,249
R01 · FY2024 · NS
The Primate Corticospinal Connectome and Transcriptome$614,442
R01 · FY2024 · NS · contact PI
Rapid In Vivo Screening of Combination Gene Therapies for Axonal Regeneration after Spinal Cord Injury$437,250
R21 · FY2024 · NS
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$394,965
R01 · FY2024 · AG · contact PI
SCI Consortium Study: 3D Printed Scaffolds for Primate Spinal Cord Injury Repair$0
I01 · FY2024 · VA
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease$1,128,467
R01 · FY2023 · AG · contact PI
Embryonic Stem Cell Therapy after Cervical Contusion SCI in NHPs$686,723
R01 · FY2023 · NS
The Primate Corticospinal Connectome and Transcriptome$630,880
R01 · FY2023 · NS · contact PI
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$394,401
R01 · FY2023 · AG · contact PI
The Primate Corticospinal Connectome and Transcriptome - Supplement$149,000
R01 · FY2023 · NS · contact PI
Advancing human neural progenitor cells (hNPCs) to FDA IND approval$0
IU1 · FY2023 · VA · contact PI
SCI Consortium Study: 3D Printed Scaffolds for Primate Spinal Cord Injury Repair$0
I01 · FY2023 · VA
RR&D Gordon Mansfield Spinal Cord Injury Consortium$0
I50 · FY2023 · VA · contact PI
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease$1,141,927
R01 · FY2022 · AG · contact PI
The Primate Corticospinal Connectome and Transcriptome$636,273
R01 · FY2022 · NS · contact PI
3D Printed Scaffolds for Primate Spinal Cord Injury Repair$634,321
R01 · FY2022 · NS · contact PI
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$394,412
R01 · FY2022 · AG · contact PI
SCI Consortium Study: 3D Printed Scaffolds for Primate Spinal Cord Injury Repair$0
I01 · FY2022 · VA
RR&D Gordon Mansfield Spinal Cord Injury Consortium$0
I50 · FY2022 · VA · contact PI
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease$1,201,473
R01 · FY2021 · AG · contact PI
The Primate Corticospinal Connectome and Transcriptome$663,402
R01 · FY2021 · NS · contact PI
3D Printed Scaffolds for Primate Spinal Cord Injury Repair$655,898
R01 · FY2021 · NS · contact PI
Embryonic stem cell therapy after cervical contusion SCI in NHPs$558,167
R01 · FY2021 · NS
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$394,032
R01 · FY2021 · AG · contact PI
SCI Consortium Study: 3D Printed Scaffolds for Primate Spinal Cord Injury Repair$0
I01 · FY2021 · VA
RR&D Gordon Mansfield Spinal Cord Injury Consortium$0
I50 · FY2021 · VA · contact PI
3D Printed Scaffolds for Primate Spinal Cord Injury Repair$656,077
R01 · FY2020 · NS · contact PI
Embryonic stem cell therapy after cervical contusion SCI in NHPs$600,676
R01 · FY2020 · NS
The Primate Corticospinal Connectome$582,575
R01 · FY2020 · NS · contact PI
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$393,261
R01 · FY2020 · AG · contact PI
The VA Gordon Mansfield SCI Consortium$0
I50 · FY2020 · VA · contact PI
The Primate Corticospinal Connectome$592,579
R01 · FY2019 · NS · contact PI
Embryonic stem cell therapy after cervical contusion SCI in NHPs$585,564
R01 · FY2019 · NS
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease$121,471
U01 · FY2019 · AG · contact PI
The VA Gordon Mansfield SCI Consortium$0
I50 · FY2019 · VA · contact PI
The Primate Corticospinal Connectome$583,888
R01 · FY2018 · NS · contact PI
Embryonic stem cell therapy after cervical contusion SCI in NHPs$576,382
R01 · FY2018 · NS
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease$263,044
U01 · FY2018 · AG · contact PI
3D Printed Scaffolds for Primate Spinal Cord Injury$77,244
R03 · FY2018 · NS · contact PI
The VA Gordon Mansfield SCI Consortium$0
I50 · FY2018 · VA · contact PI
ShEEP request for a Zeiss LSM 880 with Airyscan confocal system$0
IS1 · FY2018 · VA · contact PI
The Primate Corticospinal Connectome$597,724
R01 · FY2017 · NS · contact PI
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease$595,644
U01 · FY2017 · AG · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$542,500
R56 · FY2017 · NS · contact PI
Embryonic stem cell therapy after cervical contusion SCI in NHPs$538,073
R01 · FY2017 · NS
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease$399,052
U01 · FY2017 · AG · contact PI
3D Printed Scaffolds for Primate Spinal Cord Injury$77,252
R03 · FY2017 · NS · contact PI
The VA Gordon Mansfield SCI Consortium$0
I50 · FY2017 · VA · contact PI
The VA Gordon Mansfield SCI Consortium$0
I50 · FY2017 · VA · contact PI
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease$925,483
U01 · FY2016 · AG · contact PI
Bioengineered Scaffolds for Spinal Cord Injury$458,566
R01 · FY2016 · EB · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$1,087,993
R01 · FY2015 · NS · contact PI
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease$861,854
U01 · FY2015 · AG · contact PI
Bioengineered Scaffolds for Spinal Cord Injury$462,221
R01 · FY2015 · EB · contact PI
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease$237,576
U01 · FY2015 · AG · contact PI
The VA Gordon Mansfield SCI Consortium$0
I50 · FY2015 · VA · contact PI
Acquisition of a Keyence BZ-X700 All-In-One Automated Imaging System$0
IS1 · FY2015 · VA · contact PI
Gene Therapy for Alzheimer's Disease$1,561,324
P01 · FY2014 · AG · contact PI
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease$1,194,177
U01 · FY2014 · AG · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$1,116,757
R01 · FY2014 · NS · contact PI
Gene Delivery and Environment in Primates$559,251
P01 · FY2014 · AG · contact PI
Bioengineered Scaffolds for Spinal Cord Injury$471,374
R01 · FY2014 · EB · contact PI
Role of Neurgeultin 1 Signaling in Neurogenesis During Aging and AD$265,791
P01 · FY2014 · AG · contact PI
Role Nicotinic Receptors, Caspase Cleavage of APP, Stress, and Neurogenesis in AD$265,787
P01 · FY2014 · AG · contact PI
Neprilysin Modification of Amyloid Processing in Models of AD$253,715
P01 · FY2014 · AG · contact PI
ADMINISTRATIVE$125,651
P01 · FY2014 · AG · contact PI
Viral Vectors$91,129
P01 · FY2014 · AG · contact PI
Contusive Spinal Cord Injury Model Development$0
I01 · FY2014 · VA · contact PI
Gene Therapy for Alzheimer's Disease$1,460,619
P01 · FY2013 · AG · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$1,129,108
R01 · FY2013 · NS · contact PI
Gene Delivery and Environment in Primates$513,656
P01 · FY2013 · AG · contact PI
Bioengineered Scaffolds for Spinal Cord Injury$472,478
R01 · FY2013 · EB · contact PI
Role of Neurgeultin 1 Signaling in Neurogenesis During Aging and AD$251,174
P01 · FY2013 · AG · contact PI
Role Nicotinic Receptors, Caspase Cleavage of APP, Stress, and Neurogenesis in AD$251,167
P01 · FY2013 · AG · contact PI
Neprilysin Modification of Amyloid Processing in Models of AD$239,762
P01 · FY2013 · AG · contact PI
ADMINISTRATIVE$118,742
P01 · FY2013 · AG · contact PI
Viral Vectors$86,118
P01 · FY2013 · AG · contact PI
Gene Therapy for Alzheimer's Disease$1,549,290
P01 · FY2012 · AG · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$1,213,714
R01 · FY2012 · NS · contact PI
Gene Delivery and Environment in Primates$547,221
P01 · FY2012 · AG · contact PI
Bioengineered Scaffolds for Spinal Cord Injury$531,487
R01 · FY2012 · EB · contact PI
Role of Neurgeultin 1 Signaling in Neurogenesis During Aging and AD$265,793
P01 · FY2012 · AG · contact PI
Role Nicotinic Receptors, Caspase Cleavage of APP, Stress, and Neurogenesis in AD$265,787
P01 · FY2012 · AG · contact PI
Neprilysin Modification of Amyloid Processing in Models of AD$253,714
P01 · FY2012 · AG · contact PI
ADMINISTRATIVE$125,647
P01 · FY2012 · AG · contact PI
Viral Vectors$91,128
P01 · FY2012 · AG · contact PI
Contusive Spinal Cord Injury Model Development$0
I01 · FY2012 · VA · contact PI
Gene Therapy for Alzheimer's Disease$1,558,722
P01 · FY2011 · AG · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$1,295,072
R01 · FY2011 · NS · contact PI
Gene Delivery and Environment in Primates$556,654
P01 · FY2011 · AG · contact PI
Role of Neurgeultin 1 Signaling in Neurogenesis During Aging and AD$265,789
P01 · FY2011 · AG · contact PI
Role Nicotinic Receptors, Caspase Cleavage of APP, Stress, and Neurogenesis in AD$265,789
P01 · FY2011 · AG · contact PI
Neprilysin Modification of Amyloid Professing in Models of AD$253,716
P01 · FY2011 · AG · contact PI
ADMINISTRATIVE$125,647
P01 · FY2011 · AG · contact PI
GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY$100,951
P51 · FY2011 · RR · contact PI
Viral Vectors$91,127
P01 · FY2011 · AG · contact PI
GENE THERAPY FOR ALZHEIMERS DISEASE$50,419
P51 · FY2011 · RR · contact PI
Gene Therapy for Alzheimer's Disease$1,633,388
P01 · FY2010 · AG · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$957,989
R01 · FY2010 · NS · contact PI
Gene Delivery and Environment in Primates$568,168
P01 · FY2010 · AG · contact PI
GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY$152,087
P51 · FY2010 · RR · contact PI
ADMINISTRATIVE$126,919
P01 · FY2010 · AG · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$950,449
R01 · FY2009 · NS · contact PI
Neurobiological Aspects of Aging$539,992
K12 · FY2009 · AG · contact PI
GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY$142,265
P51 · FY2009 · RR · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$902,707
R01 · FY2008 · NS · contact PI
Neurobiological Aspects of Aging$539,992
K12 · FY2008 · AG · contact PI
Combinatorial Approaches to SCI$537,876
R01 · FY2008 · NS · contact PI
GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY$107,585
P51 · FY2008 · RR · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$897,385
R01 · FY2007 · NS · contact PI
Neurobiological Aspects of Aging$539,992
K12 · FY2007 · AG · contact PI
Combinatorial Approaches to SCI$537,798
R01 · FY2007 · NS · contact PI
GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY$106,637
P51 · FY2007 · RR · contact PI
Plasticity and Regeneration in the Primate Spinal Cord$947,916
R01 · FY2006 · NS · contact PI
Neurobiological Aspects of Aging$539,992
K12 · FY2006 · AG · contact PI
Combinatorial Approaches to SCI$537,514
R01 · FY2006 · NS · contact PI
GENE THERAPY IN PRIMATES$514,309
P01 · FY2006 · AG · contact PI
GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY$98,912
P51 · FY2006 · RR · contact PI
Combinatorial Approaches to SCI$537,697
R01 · FY2005 · NS
GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY$110,846
P51 · FY2005 · RR
Plasticity and Regeneration in the Primate Spinal Cord$76,000
R01 · FY2005 · NS
Neurobiological Aspects of Aging$1
K12 · FY2005 · AG
Plasticity and Regeneration in the Primate Spinal Cord$564,626
R01 · FY2004 · NS
Combinatorial Approaches to SCI$531,607
R01 · FY2004 · NS
GENE THERAPY FOR TREATMENT OF SPINAL INJURY$158,150
P51 · FY2004 · RR
Plasticity and Regeneration in the Primate Spinal Cord$621,426
R01 · FY2003 · NS
Netrins and Gene Therapy After Spinal Cord Injury$194,507
R21 · FY2003 · NS
GENE THERAPY FOR TREATMENT OF SPINAL INJURY$75,675
P51 · FY2003 · RR
Plasticity and Regeneration in the Primate Spinal Cord$71,440
R01 · FY2003 · NS
GENE THERAPY FOR ALZHEIMERS DISEASE$64,743
P51 · FY2003 · RR
Plasticity and Regeneration in the Primate Spinal Cord$576,775
R01 · FY2002 · NS
GENE THERAPY IN PRIMATES$498,195
P01 · FY2002 · AG
Netrins and Gene Therapy After Spinal Cord Injury$194,507
R21 · FY2002 · NS
SAFETY &FEASIBILITY OF DIRECT IN VIVO NGF GENE TRANSFER TO PRIMATE BRAIN$0
P51 · FY2002 · RR
DIFFUSION NGF &BIOLOGICAL RESPONSE FROM BASAL FOREBRAIN CHOLINERGIC NEURONS$0
P51 · FY2002 · RR
ESTROGEN MEDIATED NEURONAL PLASTICITY IN THE BRAIN$0
P50 · FY2002 · AG
Plasticity and Regeneration in the Primate Spinal Cord$605,933
R01 · FY2001 · NS
Netrins and Gene Therapy After Spinal Cord Injury$192,947
R21 · FY2001 · NS
GENE THERAPY IN PRIMATES$0
P01 · FY2001 · AG
SAFETY &FEASIBILITY OF DIRECT IN VIVO NGF GENE TRANSFER TO PRIMATE BRAIN$0
P51 · FY2001 · RR
DIFFUSION NGF &BIOLOGICAL RESPONSE FROM BASAL FOREBRAIN CHOLINERGIC NEURONS$0
P51 · FY2001 · RR
ESTROGEN MEDIATED NEURONAL PLASTICITY IN THE BRAIN$0
P50 · FY2001 · AG
EX VIVO SCHWANN CELL GENE THERAPY FOR CNS REPAIR$195,870
R01 · FY2000 · NS
GENE THERAPY IN PRIMATES$184,254
P01 · FY2000 · AG
ESTROGEN MEDIATED NEURONAL PLASTICITY IN THE BRAIN$9,240
P50 · FY2000 · AG
ESTROGEN MEDIATED NEURONAL PLASTICITY IN THE BRAIN$0
P50 · FY2000 · AG
ESTROGEN MEDIATED NEURONAL PLASTICITY IN THE BRAIN$0
P50 · FY2000 · AG